ATE145827T1 - Verfahren zur hemmung der sauerstofftoxizität in den lungen - Google Patents

Verfahren zur hemmung der sauerstofftoxizität in den lungen

Info

Publication number
ATE145827T1
ATE145827T1 AT92105035T AT92105035T ATE145827T1 AT E145827 T1 ATE145827 T1 AT E145827T1 AT 92105035 T AT92105035 T AT 92105035T AT 92105035 T AT92105035 T AT 92105035T AT E145827 T1 ATE145827 T1 AT E145827T1
Authority
AT
Austria
Prior art keywords
lungs
oxygen toxicity
inhibiting oxygen
inhibiting
toxicity
Prior art date
Application number
AT92105035T
Other languages
English (en)
Inventor
Craig D Wegner
L Gordon Letts
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE145827T1 publication Critical patent/ATE145827T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1777—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92105035T 1991-04-03 1992-03-24 Verfahren zur hemmung der sauerstofftoxizität in den lungen ATE145827T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67987091A 1991-04-03 1991-04-03

Publications (1)

Publication Number Publication Date
ATE145827T1 true ATE145827T1 (de) 1996-12-15

Family

ID=24728710

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92105035T ATE145827T1 (de) 1991-04-03 1992-03-24 Verfahren zur hemmung der sauerstofftoxizität in den lungen

Country Status (13)

Country Link
US (1) US5310551A (de)
EP (1) EP0507187B1 (de)
JP (1) JP3228548B2 (de)
AT (1) ATE145827T1 (de)
AU (1) AU655459B2 (de)
CA (1) CA2064604C (de)
DE (1) DE69215568T2 (de)
DK (1) DK0507187T3 (de)
ES (1) ES2094837T3 (de)
GR (1) GR3022578T3 (de)
HK (1) HK1003106A1 (de)
NZ (1) NZ242192A (de)
ZA (1) ZA922408B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
GB9115364D0 (en) * 1991-07-16 1991-08-28 Wellcome Found Antibody
US5708141A (en) * 1992-05-11 1998-01-13 Corvas International, Inc. Neutrophil inhibitors
US20190290623A1 (en) * 2018-03-26 2019-09-26 The Unites States of America Represented by the Secretary of Navy Use of tiotropium bromide to prevent pulmonary oxygen toxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109123A (en) * 1988-06-14 1992-04-28 Dana Farber Cancer Institute Alteration of ability of soluble CD4 fragments to bind HIV
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
EP0387701B1 (de) * 1989-03-09 1992-08-12 Boehringer Ingelheim Pharmaceuticals Inc. Verwendung von interzellularen Adhäsions-Molekülen und deren Bindungsliganden bei der Behandlung von Asthma

Also Published As

Publication number Publication date
JP3228548B2 (ja) 2001-11-12
DK0507187T3 (da) 1997-04-07
CA2064604A1 (en) 1992-10-04
US5310551A (en) 1994-05-10
NZ242192A (en) 1997-06-24
AU655459B2 (en) 1994-12-22
EP0507187B1 (de) 1996-12-04
JPH05255103A (ja) 1993-10-05
HK1003106A1 (en) 1998-10-09
ZA922408B (en) 1992-12-30
ES2094837T3 (es) 1997-02-01
CA2064604C (en) 2007-07-10
EP0507187A1 (de) 1992-10-07
GR3022578T3 (en) 1997-05-31
DE69215568T2 (de) 1997-05-15
AU1398692A (en) 1992-10-08
DE69215568D1 (de) 1997-01-16

Similar Documents

Publication Publication Date Title
FI954092A0 (fi) Menetelmä hengityslaitteen ohjaamiseksi uniapnean hoidossa
DE69422900D1 (de) Vorrichtung zur Erzeugung eines kontinuierlichen positiven Atemwegdruckes (CPAP)
DE59201882D1 (de) Verfahren zur Erkennung der Atemphasen eines Patienten bei assistierenden Beatmungsverfahren.
DE69435330D1 (de) Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen
DK0606351T3 (da) Apparat til sikring af lungetilstanden
SE9801427D0 (sv) Förfarande för bestämning av minst en parameter samt en andningsapparat
SE9402237D0 (sv) Measurement methods and systems
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
MX9200902A (es) Metodo de anestesia.
DE69204639D1 (de) Verwendung von Modafinil zur Herstellung eines antiischämischen Arzneimittels.
FI95873C (fi) Inhalaatiolaitteen yhteydessä käytettävä venttiili
DK0494405T3 (da) Anvendelse af thiazolidin-4-carboxylatderivater til behandling af lungesygdomme
ATE143260T1 (de) Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DK0699414T3 (da) Anlæg til sygdomsbehandling
ATE145827T1 (de) Verfahren zur hemmung der sauerstofftoxizität in den lungen
ATE181549T1 (de) Verfahren zur herstellung von (s)-3-amino-1- substituiert-pirrolidine
ATE162218T1 (de) Verfahren zur herstellung eines virussicheren thrombinkonzentrates
ATE121420T1 (de) Verfahren zur herstellung von 3-(l-pyroglutamyl)- l-thiazolidin-4-carbonsäure-derivaten.
DE68919228D1 (de) Verfahren zur erhöhung des molekulargewichts eines polyamids.
DE59105327D1 (de) Verfahren zur Herstellung eines Feuchthaltemittels.
SE8903764L (sv) Lung protection agents
ATE258926T1 (de) Verfahren zur herstellung von ranitidin
ATE148991T1 (de) Nicotinamid-adenin-dinukleodid enthaltendes antidepressionsmittel
DK0458536T3 (da) Terapeutisk middel til behandling og forebyggelse af åndedrætsbesværsyndrom hos voksne

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification